Omnipod 5 DEXG7G6 pods (GEN 5) 5S
Ended Awarded Last action
- Contract number
- SPE2DR26F21QT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,201
Award facts
- Contract value 100% obligated
- $18,201.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,201.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 30, 2026, for the supply of OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. Performance will be completed by February 2, 2026, at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement. The company supplies a broad portfolio of pharmaceutical products and medical devices to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This contract for insulin delivery pods supports diabetes management capabilities within the Military Health System, consistent with DLA's broader medical supply chain operations that furnish prescription medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to active duty personnel, retirees, and their families globally.
Quick answers
Who was awarded contract SPE2DR26F21QT?
SPE2DR26F21QT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F21QT worth?
The government has obligated $18,201 on SPE2DR26F21QT.
Is contract SPE2DR26F21QT an order under another contract?
Yes. SPE2DR26F21QT is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21QT competed?
The extent of competition for SPE2DR26F21QT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award